Brief: Ajanta Pharma gets US FDA approval for Omeprazole and Sodium Bicarbonate Powder
July 29 (Reuters) - Ajanta Pharma Ltd AJPH.NS : * Ajanta Pharma announces US FDA approval for Omeprazole and Sodium Bicarbonate Powder for Oral Suspension * Source text: http://bit.ly/2aOuDnj * Further company coverage AJPH.NS ((Bengaluru Newsroom; +91 80 6749 1130))
Recent news on Ajanta Pharma
See all newsIndia's Ajanta Pharma falls as analysts say growth to moderate in H2
Brief: Ajanta Pharma Limited Sept-Quarter Consol Net Profit 3.88 Billion Rupees
India's Ajanta Pharma jumps on June quarter profit jump
Brief: Ajanta Pharma June-Quarter Consol PAT 3.34 Billion Rupees
Brief: Ajanta Pharma Receives US FDA Establishment Inspection Report For Paithan Facility